Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Cash Flow: 2012-2024

Historic Net Cash Flow for Neurogene (NGNE) over the last 13 years, with Dec 2024 value amounting to -$11.8 million.

  • Neurogene's Net Cash Flow rose 127.46% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 79.63%. This contributed to the annual value of -$11.8 million for FY2024, which is 117.68% down from last year.
  • Latest data reveals that Neurogene reported Net Cash Flow of -$11.8 million as of FY2024, which was down 117.68% from $66.7 million recorded in FY2023.
  • In the past 5 years, Neurogene's Net Cash Flow ranged from a high of $66.7 million in FY2023 and a low of -$50.1 million during FY2021.
  • Moreover, its 3-year median value for Net Cash Flow was $11.5 million (2022), whereas its average is $22.1 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first slumped by 199.50% in 2021, then soared by 481.14% in 2023.
  • Over the past 5 years, Neurogene's Net Cash Flow (Yearly) stood at $50.3 million in 2020, then crashed by 199.50% to -$50.1 million in 2021, then surged by 122.91% to $11.5 million in 2022, then skyrocketed by 481.14% to $66.7 million in 2023, then crashed by 117.68% to -$11.8 million in 2024.